The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

Parkinson's Disease Clinical Trial

Official title:

The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00766948
• Other study ID #: HSC# 08-5022
• Status: Active, not recruiting
• Start date: August 2008
• Est. completion date: August 2030

Study information

• Verified date: March 2021
• Source: Scripps Translational Science Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 100
• Est. completion date: August 2030
• Est. primary completion date: August 2030
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years and older

Eligibility

Inclusion Criteria:

• Is age 30 years or older at the time of onset of Parkinson's

• Has been diagnosed with idiopathic Parkinson's Disease by a Scripps Neurologist

• Is reliable, cooperative and willing to comply with all protocol-specified procedures and/or sub-study if consented or have legal representative/guardian willing to do so

• Able to understand and grant informed consent or have a legal representative/ guardian who is able to do so

Exclusion Criteria:

• Patient has been previously enrolled in The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

• If a blood draw would be contraindicated for any reason

• Has a significant chronic medical condition (i.e. CVA, hepatic encephalopathy) which, in the investigator's option, may interfere with the patient's optimal participation in the study

• Treatment with any investigational agents or devices within 30 days preceding enrollment in the study

• Has undergone ECT within 90 days preceding enrollment in the study

Related Conditions & MeSH terms

• Parkinson Disease
• Parkinson's Disease

Intervention

Other:
• There is no intervention, this is a biorepository.
There are no interventions in this study.

Locations

Country	Name	City	State
United States	Scripps Clinic, Torrey Pines	La Jolla	California
United States	Scripps Translational Science Institute	La Jolla	California
United States	The Scripps Research Institute	La Jolla	California

Sponsors (3)

Lead Sponsor	Collaborator
Scripps Translational Science Institute	Scripps Health, The Scripps Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Neurogenetic databank	initiate a Parkinson's disease neurogenetic databank by obtaining blood samples in order to define genes for Parkinson's disease and other neurological conditions.	Study completion